Cargando…
Induction of Anti-Proliferative and Apoptotic Effects of Sorafenib Using miR-27a Inhibitor in Hepatocellular Carcinoma Cell Lines
OBJECTIVE: The purpose of the current study was to investigate the possible anti-tumor effect of miR-27a inhibitor in combination with Sorafenib (SOR) on cell proliferation and apoptosis of hepatocellular carcinoma cell lines. METHODS: Transient transfection by oligo-miR27a inhibitor (miR-27ai) was...
Autores principales: | Abdel Wahab, Abdel Hady A, Ayad, Eman G, Abdulla, Mohga S, Sharada, Hayat M, Ashmawy, Abeer M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850906/ https://www.ncbi.nlm.nih.gov/pubmed/34582667 http://dx.doi.org/10.31557/APJCP.2021.22.9.2951 |
Ejemplares similares
-
Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer
por: Mohammed, Mohammed A, et al.
Publicado: (2013) -
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells
por: Youssef , Mohieldin M., et al.
Publicado: (2016) -
Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver
por: Ahmed, Emad K., et al.
Publicado: (2019) -
Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest
por: Abdel Salam, Nagwa M, et al.
Publicado: (2021) -
Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients
por: Abdelaziz, Heba E., et al.
Publicado: (2022)